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Abstract 20 
The isolation of antimicrobial resistant bacteria (ARB) from wildlife living adjacent to humans has led 21 
to the suggestion that such antimicrobial resistance (AMR) is anthropogenically driven by exposure to 22 
antimicrobials and ARB. However, ARB have also been detected in wildlife living in areas without 23 
interaction with humans.  Here, we investigated patterns of resistance in Escherichia coli isolated from 24 
408 wild bird and mammal faecal samples. AMR and multi-drug resistance (MDR) prevalence in 25 
wildlife samples differed significantly between a Sewage Treatment Plant (STP; wastes of antibiotic-26 
treated humans) and a Farm site (antibiotic-treated livestock wastes) and Central site (no sources of 27 
wastes containing anthropogenic AMR or antimicrobials), but patterns of resistance also varied 28 
significantly over time and between mammals and birds. Over 30% of AMR isolates were resistant to 29 
colistin, a last-resort antibiotic, but resistance was not due to the mcr-1 gene. ESBL and AmpC activity 30 
were common in isolates from mammals. Wildlife were, therefore, harbouring resistance of clinical 31 
relevance.  AMR E. coli, including MDR, were found in diverse wildlife species, and the patterns and 32 
prevalence of resistance were not consistently associated with site and therefore different exposure 33 
risks. We conclude that AMR in commensal bacteria of wildlife is not driven simply by anthropogenic 34 
factors, and, in practical terms, this may limit the utility of wildlife as sentinels of spatial variation in 35 
the transmission of environmental AMR. 36 
 37 
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1. Introduction 42 
Antimicrobial resistance (AMR) has existed for millions of years, and is an inevitable 43 
evolutionary consequence of microbial competition in the environment (D'Costa et al 2011, Davies 44 
and Davies 2010, Martinez 2009). While the increasing prevalence of AMR in clinically important and 45 
commensal bacteria in both humans and livestock can be attributed largely to selection through the 46 
use of antimicrobials (Ibrahim et al 2016, Karesh et al 2012), AMR has also been reported in the 47 
commensal bacteria of wildlife (Arnold et al 2016). Commensal bacteria have the potential to act as 48 
reservoirs of resistance genes, contributing to the development of AMR in pathogens by horizontal 49 
transmission (Arnold et al 2016, Taylor et al 2011, von Wintersdorff et al 2016).  AMR is a problem in 50 
human and veterinary medicine worldwide, inhibiting the treatment of bacterial infections and is 51 
estimated to be responsible for 25,000 preventable human deaths in Europe annually (Marston et al 52 
2016) and an estimated global economic cost of 100 trillion USD by 2050 if not addressed (O'Neill 53 
2016). Thus, there is increasing interest in the environment, including wildlife, as both a source of 54 
clinically relevant AMR and in order to better understand the effects of anthropogenically-derived 55 
antimicrobial pollution and resistance in ecosystems (Arnold et al 2016, Carroll et al 2015, Huijbers et 56 
al 2015). 57 
It is often assumed that antimicrobial-resistant bacteria (ARB) in wildlife result from contact 58 
with anthropogenic sources such as farms and human waste that pollute the environment with AMR 59 
bacteria and/or with antimicrobials (Allen et al 2010, Clarke and Smith 2011, Radhouani et al 2011).  60 
Farms on which manure and slurry can be contaminated with ARB, antibiotics (or their metabolites) 61 
and other selective drivers of AMR are important habitats for many small mammals and birds, as are  62 
sewage treatment plants (STPs) where some birds and mammals feed directly from the bioprocessers 63 
(reviewed in Arnold et al 2016). Run-off from farms, slurry tanks and manure-fertilised fields, along 64 
with sewage effluent, can result in antimicrobial drug and ARB contamination of local water courses 65 
and land (Fahrenfeld et al 2013). Consequently, it is unsurprising that ARB have been found in wild 66 
4 
 
animals in close contact with humans (Allen et al 2011, Bondo et al 2016, Furness et al 2017, Gilliver 67 
et al 1999). 68 
Assigning the source and directionality of AMR dissemination is challenging. Even within 69 
wildlife populations living in close contact with humans or livestock, or at least their wastes, there is 70 
little evidence directly linking an anthropogenic source of AMR with specific patterns of AMR and/or 71 
resistance genes. For example, few overlaps in resistance patterns and AMR genes were found 72 
between E. coli isolated from wildlife living on or near dairy farms and dairy cattle in England (Arnold 73 
et al 2016, Wu et al 2018). Whereas wild rodents nearer to a river receiving sewage effluent excreted 74 
more resistant E. coli than inland animals (Furness et al 2017), this was an association lacking evidence 75 
of a clear transmission pathway. Moreover, other highly mobile taxa such as birds also carry ARB that 76 
have not been attributed to any particular anthropogenic source (Guenther et al 2017, Schaufler et al 77 
2016). Moreover, AMR has been detected in wildlife living in remote and isolated locations with no 78 
obvious contact with the wastes of antimicrobial-treated humans or livestock (Cristobal-Azkarate et 79 
al 2014). Thus, although transmission of AMR from humans or livestock to wildlife via direct contact 80 
with sewage, slurry or faeces, has been suggested, the empirical evidence is lacking or contradictory. 81 
Species or ecological guilds with different dispersal patterns, resource requirements and foraging 82 
behaviours are likely to have different roles in the evolution and dispersal of AMR (Arnold et al 2016). 83 
We argue that the efficacy of wildlife species as sentinels of environmental transmission of AMR will 84 
vary depending on the spatial and temporal scales of interest. 85 
In this study, three nearby communities of small wild rodents and birds were investigated for 86 
evidence of AMR in faeces. The antimicrobials used to screen for resistance were chosen as they 87 
represent a range of antibiotic classes of medical and veterinary interest. For example, cefpodoxime 88 
resistance is seen as an indicator of extended spectrum beta-lactamase (ESBL) or AmpC beta-89 
lactamase producing bacteria which cause significant problems in human medicine especially with 90 
urinary tract infections (Rawat and Nair 2010). Colistin resistance is also of relevance due to colistin 91 
being an antibiotic of last resort. The sites for sampling were chosen to represent different exposures 92 
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to wastes and thus potentially different selection pressures for AMR: a dairy farm with antimicrobial-93 
treated livestock, a STP containing waste from humans treated by antimicrobials and an area of 94 
parkland and neighbouring arable field edge with no obvious sources of waste containing 95 
antimicrobials or ARB. We sampled wildlife species typical for small woodlands, farmland and 96 
hedgerow habitats in the UK; small rodents including wood mice Apodemus sylvacticus, bank voles 97 
Myodes glareolus and a number of bird species.  98 
The overall aim of this study was to investigate the role of environmental contamination in 99 
the patterns of AMR found in wildlife.  We addressed whether the spatial location where wild birds 100 
and mammals were sampled, including proximity to human and livestock wastes, explained variation 101 
in: 1) prevalence and genomic diversity of AMR E. coli in birds and mammals; 2) patterns of AMR and 102 
MDR prevalence in E. coli isolates; and 3) prevalence of phenotypic resistance to medically important 103 
antimicrobials and the resistance genes responsible.  104 
 105 
2. Material and Methods 106 
2.1 Study sites 107 
Three nearby study sites in the East Midlands of England, on a 1200m transect, were selected 108 
(Figure S1), based on their differing potential exposure to human and livestock sources of AMR and 109 
antimicrobial drugs. The ‘Farm site’ was a small woodland and hedgerows immediately adjacent to a 110 
dairy farm that received run-off from farm buildings and livestock faeces potentially contaminated 111 
with AMR bacteria and antimicrobials. The ‘Central site’, around 600m from the Farm site, comprised 112 
an arboretum and neighbouring hedgerow edging an arable field.  It was not adjacent to known 113 
sources of human or livestock waste. The ‘STP site’ was a small sewage treatment plant around 450-114 
600m from the Central-site, comprising the land and hedgerows surrounding all the tanks and trickling 115 
filters making up the STP and hedgerows adjacent to the pipe where treated water outflowed into a 116 
local stream. All the sites were close enough to share common environmental traits and weather. 117 
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Conversely, the three sites were far enough apart, with physical barriers to dispersal (roads and a 118 
railway line), such that most of the species sampled would not regularly move between the sites. 119 
2.2 Sampling wildlife 120 
All sampling took place between July and August (‘Summer’), and October and November 121 
(‘Autumn’) 2016 and was subject to full ethical review (see Supplementary Material). Sampling 122 
occurred each week per month per site, but mammals and birds were not captured simultaneously to 123 
avoid excessive disturbance. Small mammals were trapped in Longworth or similar live, small mammal 124 
traps with shrew escape holes. The traps were sterilised between sites, filled with sterile hay as 125 
bedding and mixed grain and carrot or apple as food and water sources. Traps were placed at 5m 126 
intervals and checked daily. Faeces were collected with a sterile swab into a sterile sampling tube for 127 
transport to the laboratory. The species of each rodent caught, the date and trap location were 128 
recorded.   129 
Wild birds were caught in mist nets, under licence from the British Trust for Ornithology (BTO), 130 
located along and across hedgerows and patches of woodland within each study site. Each capture 131 
location was selected to overlap with trapping sites for small mammals (above) and was pre-baited 132 
for at least 3 days with bird feeders containing mixed seed.  After capture, each bird was placed on its 133 
own into a single use brown paper bag for up to 20 min in order to collect a faecal sample. The bird 134 
was then fitted with a BTO leg ring, before being released. Sterile swabs were used to remove faeces 135 
from the bags into sterile sampling tubes. If the same bird was caught more than once on the same 136 
day the faecal samples were pooled.  In addition, feral pigeons, which formed a large flock at the Farm-137 
site, were sampled for faeces post-mortem after shooting as part of pest control. Table S3 shows the 138 
range of species caught. The foraging ecology of the species did not explain any of the patterns of 139 
AMR or MDR observed (see Supplementary Material). 140 
 141 
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2.3 Isolation and AMR characterisation of presumptive E. coli isolates 142 
Phenotypic resistance to eight antibiotics was determined first by plating on antibiotic-143 
supplemented media or by disk diffusion. Faecal samples (0.5 g) were incubated in buffered peptone 144 
water (BPW) at 37 °C for 18 h and 100 µl was spread onto Tryptone Bile X-Glucuronide Medium (TBX; 145 
Oxoid, UK) agar supplemented with; ampicillin (10 μg/ml), apramycin (30 μg/ml), colistin (4 μg/ml) or 146 
ciprofloxacin (1 μg/ml) or without antibiotics and incubated at 37°C for 18h.  Presumptive E. coli 147 
(blue/green) colonies were taken forward for further characterisation.   148 
One presumptive antibiotic resistant E. coli colony per plate obtained from the initial 149 
screening was then tested for resistance to other antibiotics using disc diffusion assays. Briefly, isolates 150 
were cultured in BPW at 37 oC for 18 h. Samples (100 µl) were spread plated onto Muller-Hinton agar 151 
(MH; Oxoid, UK) and left to dry. Six antibiotic discs impregnated with ampicillin (10 μg/ml), tetracycline 152 
(3 μg/ml), apramycin (15 μg/ml), trimethoprim (2.5 μg/ml), imipenem (10 μg/ml) and cefpodoxime 153 
(10 μg/ml), were placed on the agar and the plates were incubated for 18 h at 37 oC.  After incubation 154 
the diameter of the zone of clearance around each disc was measured and isolates were classified as 155 
resistant if the zone was less than or equal to published breakpoints (EUCAST 2016). 156 
 157 
2.4 Characterisation and ERIC-PCR genotyping of E. coli isolates 158 
A randomly selected subsample of presumptive E. coli were subject to rRNA PCR and 159 
sequencing (Srinivasan et al 2015). BLAST searches confirmed all were Escherichia, and the vast 160 
majority clearly E. coli. In order to identify any patterns of genotypic similarity among E. coli by spatial 161 
location or host (mammal/bird), we used ERIC-PCR. Twenty-four resistant E. coli isolates from 162 
mammals at each sample site and all the resistant E. coli isolates from birds (total 91 samples) were 163 
subjected to ERIC-PCR (Ibrahim et al 2016, Versalovic et al 1991). DNA (diluted 1:100) extracted from 164 
the E. coli isolates, 12.5 µl of PCR Master Mix Plus (Qiagen, UK), 5 µM of the each ERIC primer (Table 165 
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S1), 2 µl of Coral Load Dye (Qiagen, UK) and sterile molecular grade water to 25 µl. The PCR parameters 166 
for the ERIC-PCR are found in Table S1. 167 
 168 
2.5 Analysis of ESBL and AmpC resistance in cefpodoxime-resistant E. coli 169 
 Cefpodoxime resistant isolates were tested for ESBL or AmpC activity using the AmpC & ESBL 170 
Detection Set (Mast Group, UK). Briefly, overnight liquid cultures of cefpodoxime resistant isolates 171 
were spread plated onto MH agar and left to dry before discs containing cefpodoxime 10 µg (A), 172 
cefpodoxime 10 µg + ESBL inhibitor (B), cefpodoxime 10 µg + AmpC inhibitor (C) ad cefpodoxime 10 173 
µg + ESBL and AmpC inhibitor (D) were added. Comparison of the zones of clearance enabled ESBL 174 
and/or AmpC resistant bacteria to be identified using the manufacturer’s calculator (Mast Group, 175 
UK). 176 
 177 
2.6 DNA extraction and PCR parameters 178 
DNA was extracted from E. coli by heat-lysis. One colony was placed in 10 μl of sterile 179 
molecular grade water and heated at 95° for 10 min. Samples were centrifuged (13000 x g; 3 min) and 180 
the supernatant removed. The supernatant was stored at -20 oC until used as template DNA for 181 
subsequent PCR reactions. PCR amplifications (apart from ERIC-PCR) were carried out in 20 µl reaction 182 
mixtures comprising of 10 µl of PCR Master Mix Plus (Qiagen, UK): 0.5 µM of each primer, 2 µl of Coral 183 
Loading Dye (Qiagen, UK) and molecular grade sterile water to 20 µl. See Table S1 for primers and PCR 184 
cycling parameters. 185 
 186 
2.7 Molecular characterisation of colistin and ciprofloxacin resistant E. coli  187 
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E. coli isolates with phenotypic colistin and ciprofloxacin resistance were further 188 
characterised. DNA from ciprofloxacin and colistin-resistant colonies was diluted 1:100 and used as 189 
template DNA for PCR to amplify the gyrA and if present the transposable mcr-1 gene (Liu et al 2016). 190 
For ciprofloxacin resistant isolates DNA was purified from agarose gels using a Gel DNA Extraction Kit 191 
(ZymoResearch, UK) and sequenced. The sequences were aligned and compared against E. coli K12 192 
using CLC SequenceCe Viewer (Qiagen) to identify specific point mutations in gyrA associated with 193 
ciprofloxacin resistance. As a positive control for colistin resistance, DNA harbouring the mcr-1 gene 194 
was used. 195 
 196 
2.8 Statistical analyses 197 
Binomial logistic regression models were used to ascertain the effects of site (Farm, Central 198 
and STP), season (Summer = Jul/Aug, Autumn = Oct/Nov,) and taxa (bird or mammal) on the 199 
prevalence of E. coli in faecal samples and prevalence of resistance, i.e. if E.coli were resistant to one 200 
or more antibiotic (‘AMR ≥1 antibiotic’) or MDR (resistant to three or more antibiotics). All of these 201 
analyses were carried out using SPSS v.24. 202 
The ERIC-PCR gel image was analysed using a Gel-Doc XR system (Bio-Rad, UK)(Ibrahim et al 203 
2016). Using GelCompar II (Applied Maths) a dendrogram was generated from the comparison of ERIC-204 
PCR profiles, using the Dice coefficient, and clustered by the unweighted pair group method with 205 
arithmetic averages (UPGMA) with 1.5% of optimization and 1.5% of tolerance. Molecular variance 206 
framework analysis (AMOVA) (Excoffier et al 1992) was used to analyse the confidence of the selected 207 
similarity threshold and the significance of clusters. The AMOVA calculation was carried out using 208 
GenAlEx v 6.5b5 software (Peakall and Smouse 2006). The significance was examined with the 209 
calculation of ΦPT, a measure of population differentiation that suppresses intra-individual variation. 210 
In the case of AMOVA, the null hypothesis (H0; ΦPT = 0) meant that there was no genetic difference 211 
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among the populations and the alternative hypothesis (H1; ΦPT > 0) meant there were genetic 212 
differences amongst the populations. 213 
 214 
  215 
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3. Results 216 
3.1 E. coli in rodent and avian samples 217 
In total, 125 faecal samples from bank voles, 15 from field voles and 89 from wood mice were 218 
collected. A further 96 faecal samples were collected from traps in which small rodents had escaped, 219 
and were recorded as ‘unknown’ (see Table S2). We collected 84 avian faecal samples from 18 220 
different species, but one sample did not yield an isolate. 221 
Overall E. coli were isolated from 66 % (269/408) of faecal samples (Figure 1).  The prevalence 222 
of E. coli was explained by site, season and taxa (Table 1a). Samples collected from the Central (63%; 223 
n= 145) and STP sites (64%; n= 125) did not differ significantly. Samples collected from the Farm Site 224 
(prevalence = 71 %; n = 138) were significantly more likely to contain E. coli than those from the Central 225 
Site (Table 1a; Figure 1). Mammalian samples were significantly more likely to contain E. coli 226 
(prevalence = 74%; n = 325) than avian samples (33%; n = 83)(Table 1a). Samples collected in Summer 227 
(prevalence = 73%; n = 227) were significantly more likely to contain E.coli than those collected in 228 
Autumn (57%; n = 181)(Table 1a).    229 
 230 
3.2 Genotyping of E. coli isolates by ERIC-PCR 231 
A selection of AMR E. coli representing different hosts and sites were compared by ERIC-PCR 232 
(Figure 2). Cluster analysis suggested five main groups of isolates at a 50 % similarity threshold 233 
(indicated as 1-V in Figure 2). Cluster significance analysis demonstrated these were non-overlapping 234 
and hence genomically independent groups (cluster significance ΦPT = 0.036; p < 0.001). Each larger 235 
cluster (II-V) contained E. coli from a range of hosts and sites with no obvious association between 236 
their AMR pattern and which cluster the isolates resided in. However, there was a tendency towards 237 
certain clusters containing isolates from predominantly one site: cluster II with Farm Site, cluster III 238 
with Central Site and cluster V with STP Site. Given an expected probability of 0.33, binomial tests 239 
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indicated that the proportion (0.69) of Farm Site samples in Cluster II was significantly higher than 240 
expected (p = 0.0002), as was the proportion  of Central Site samples (0.62) in Cluster III (p = 0.033) 241 
and the proportion of Farm Site samples (0.75) in Cluster V (p = 0.0006). 242 
 243 
3.3. Antimicrobial resistance 244 
 The prevalence of AMR was expressed as the percentage of samples from which E. coli was 245 
isolated (on the TBX plate without antibiotics) that also contained at least one isolate resistant to at 246 
least one of the antibiotics tested (AMR ≥ 1).  The overall prevalence of AMR E. coli was 54 % (n = 247 
262) and was significantly explained by a model that included season, taxa and site (Table 1b). AMR 248 
prevalence in samples from the STP was 61.3 % (n = 80) which was significantly higher than the 249 
prevalence of resistance in samples from the Central Site (50.0 %; n = 86) (Table 1b; Figure 3a). 250 
Prevalence in samples from the Farm site was 52.1 % (n = 96) and did not significantly differ from 251 
that in Central Site samples (Table 1b). 252 
E. coli from samples collected in Summer (prevalence = 65.4 %; n = 159) were significantly 253 
more likely to be resistant than those collected in Autumn (36.9 %; n = 103) Table 1b). There was a 254 
tendency (p = 0.056; Table 1b) for mammalian faecal samples to have a higher prevalence (55.7 %; n 255 
= 235) of resistant E. coli than avian samples (40.7 %; n = 27). 256 
 257 
3.4 Multi-drug resistance (MDR) 258 
For the purpose of this study MDR was defined as resistance to three or more of the eight classes of 259 
antibiotics tested.  Overall, 80.3 % (n = 142) of the AMR E. coli were MDR. A model including taxa 260 
and site significantly explained MDR prevalence (Table 1c). Prevalence in samples from the Farm site 261 
(66.0 %; n = 50), was significantly lower than from the Central site (83.7 %; n = 43). Prevalence of 262 
MDR in samples from the Central and STP sites (91.8 %; n = 49) did not differ significantly (Fig. 3b; 263 
Table 1c). E. coli from samples collected from mammals (prevalence = 84.7 %; n = 131) were 264 
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significantly more likely to be MDR than those collected from birds (27.3%; n = 11) (Table 1c).  265 
Season (MDR prevalence in Summer = 77.9 %; n = 104 and in Autumn = 86.8 %; n=38) was non-266 
significant so was excluded from the model.  267 
Individual E. coli isolates were resistant to up to seven different antibiotics (Figure 3c).There 268 
was no obvious difference in MDR profiles between the different sites tested (Table 2). 269 
3.5 Prevalence of ESBL or AmpC producing E. coli 270 
All isolates resistant to cefpodoxime were further investigated for ESBL or AmpC production. 271 
From the 53 cefpodoxime resistant E. coli, six were ESBL, 22 were AmpC and six were positive for both 272 
ESBL and AmpC production (Table 3). Across all samples, there was a significant difference between 273 
the sites in the number of isolates testing positive for AMPC and/or ESBL, with the highest number at 274 
the STP site (χ2 (2) = 6.59, p = 0.034; Table 3). 275 
 276 
3.6 Genotypic analysis of ciprofloxacin and colistin resistant isolates  277 
 Ciprofloxacin resistant E. coli were further characterised by sequence comparison with a 278 
known sensitive strain of E. coli (K-12) and four of amino acid changes were observed (Figure 4). All 279 
colistin resistant isolates were subjected to mcr-1 PCR and none were found to be positive for this 280 
gene, suggesting resistance is derived from other ARGs. 281 
 282 
  283 
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4. Discussion 284 
AMR, including MDR, was common among the commensal E. coli of the wildlife studied, but 285 
clear patterns in resistance were not seen in terms of spatial proximity to anthropogenic sources of 286 
waste containing antimicrobials and ARB. Previous studies have suggested that wildlife could be 287 
used as sentinels of environmental AMR (Furness et al 2017, Vittecoq et al 2016). Our study supports 288 
this to some extent, although as with previous work by ourselves and others (Arnold et al 2016, 289 
Bondo et al 2016, Gilliver et al 1999, Literak et al 2010, Williams et al 2011), factors other than 290 
geographic distance from the wastes of antibiotic treated animals or humans clearly influence AMR.  291 
This is also demonstrated by the wide variations in MDR profiles within and between sites suggesting 292 
other factors affecting AMR in these animals (Table 2). Host taxonomic differences, as well as spatial 293 
and temporal factors, seemed to influence AMR prevalence. Moreover, our models explained about 294 
20% of the variance in AMR and MDR, indicating that other, unmeasured factors, were also 295 
important in determining prevalence. Thus, there are significant caveats to using wildlife as sentinels 296 
of environmental transmission of AMR due to antimicrobials and ARB in anthropogenic wastes. 297 
 Some studies have reported relatively high AMR prevalence in wildlife collected near AMR 298 
sources such as water bodies receiving sewage effluent or agricultural wastes, compared with more 299 
pristine sites (Bonnedahl et al 2009, Furness et al 2017). In our study, a significantly higher 300 
prevalence of AMR was observed at the STP (61%) compared with the other two sites (<53%). That 301 
site and site-specific environments might be drivers of exposure is supported by the ERIC analysis 302 
that found that genotypes of E. coli showed spatial- rather than host-specific clustering (VanderWaal 303 
et al 2014).   Multidrug resistance prevalence showed somewhat different patterns with the STP 304 
(92%) again having a significantly higher MDR prevalence than the farm (66%), but a similar 305 
prevalence to the Central site (84%).  If the prevalence and patterns of resistance were driven by 306 
exposure to either anthropogenic antimicrobials or ARB from humans and/or livestock, a higher 307 
prevalence of resistance would have been expected at the Farm Site as well as the STP Site, and the 308 
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prevalence at the Central site might have been expected to be lower than both of the other two 309 
sites. However, this was not the case (see also (Carter et al 2018).  310 
 311 
4.1 Host taxa and temporal variation 312 
 Taxonomic differences in both the prevalence of samples containing E. coli and the 313 
prevalence of AMR and MDR were observed. Mammals (74%) were significantly more likely to be 314 
carrying E. coli than birds (33%), with a prevalence of 66% overall. Host taxonomic differences in E. 315 
coli may reflect the relatively small size of faecal samples from birds and their tendency to dry out, 316 
but might also simply reflect the relative contribution of E. coli to the normal gut biota of very 317 
different taxa.  The prevalence of phenotypic AMR (expressed as the percentage of samples that 318 
contained resistant E. coli) was 54% overall, with a marginally higher prevalence in mammalian 319 
(56%) than avian (41%) samples (p = 0.056). Our prevalence of ARB in mammals was similar to that 320 
previously reported in the UK (35% and 79% for inland and coastal populations respectively of small 321 
mammals (Furness et al 2017), but higher than that reported in similar species from mainland 322 
Europe (for example 5.5% AMR in E. coli from rural small mammals in Germany (Guenther et al 323 
2010) and 2 – 12% in a range of wild mammals the Czech Republic (Literak et al 2010). Reported 324 
AMR prevalence in wild birds is similarly diverse, varying both by species and geography (Carter et al 325 
2018).  For example,  a study of AMR in E.coli from gulls across Europe found a prevalence of 32% 326 
overall, but with considerable geographic variation, from 61% in Spain to 8% in Denmark (Stedt et al 327 
2014). Notably, a larger number of avian than mammal species were sampled, so differences in 328 
ecology and diet among species might obfuscate comparisons of the relative roles of mammals and 329 
birds in AMR dispersal. 330 
 Furthermore, in our study, as in others (Ahammad et al 2014, Bondo et al 2016, Sun et al 331 
2012, Williams et al 2011), E. coli,  AMR and MDR patterns and prevalence varied over time. 332 
Temporal variation in E. coli and resistance patterns might reflect changing environmental 333 
conditions (temperature and rainfall), selective drivers (e.g. patterns in antibiotic usage) and/or food 334 
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availability (and changing gut biota) for wildlife as well as differences between the species’ 335 
population dynamics (Waite and Taylor 2014, Williams et al 2011). Since sampling took place during 336 
only two seasons, temporal and seasonal patterns in AMR evolution and dispersal need further 337 
study. Despite some limitations, our study lays the foundations for future studies looking a larger 338 
numbers of animals at a wider variety of sites and, ideally, longitudinally, along with direct sampling 339 
of the environment for antibiotics and ARB. 340 
 341 
4.2 MDR prevalence and resistance profiles 342 
 As described in other studies (Arnold et al 2016, Williams et al 2011), many AMR isolates 343 
from mammalian wildlife were multidrug-resistant (MDR). This was likely an outcome of prevalent 344 
mobile genetic elements such as plasmids and transposons (Carroll et al 2015), but chromosomal 345 
mutations are also common. The prevalence of MDR (AMR ≥3), like overall AMR (AMR ≥1) was 346 
higher in mammal (85%) than in bird samples (27%). On the other hand, the large diversity of MDR 347 
profiles found (Table 2) suggests only limited MDR transmission between individuals. Some of these 348 
resistances (ciprofloxacin) were found to be derived from point mutations and therefore are not 349 
necessarily linked to the other resistances carried by the individual bacterium. Moreover, MDR 350 
prevalence was highest at the STP. It is tempting, therefore, to speculate that animals at the STP Site 351 
were exposed to a wider range of MDR bacteria, plasmids, or antimicrobials, than animals at other 352 
sites. This in turn would fit well with a hypothesis that these animals had exposure to sewage 353 
derived from many different people, with different histories of antimicrobial exposure, whereas 354 
wildlife at the Central and Farm Sites would have exposure to less varied sources and drivers. This 355 
would still, however, leave unanswered the questions of what might be the drivers that led to such 356 
high MDR prevalence overall, why different animals in the same population might have such 357 
different exposure histories and why the Farm Site and not the Central Site had the lowest MDR 358 
prevalence.  359 
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The most common MDR resistance profile encountered in this study was combined 360 
resistance to ampicillin, colistin and ciprofloxacin (Table 2). A high prevalence of resistance to 361 
ampicillin was expected as this beta-lactam antibiotic is frequently used in both human and 362 
veterinary medicine and resistance is common not only in clinical samples (Briñas et al 2002) but has 363 
also been described previously in wild rodents (Arnold et al 2016, Williams et al 2011). It is 364 
commonly plasmid-encoded and associated with MDR, as in this study where 83% of the ampicillin 365 
resistant isolates were resistant to three or more antibiotics and 23% to five or more antibiotics 366 
(Table 2). A high prevalence of phenotypic resistance to colistin was neither expected nor has been 367 
described previously in wild rodents, although colistin-resistant E. coli strains have been isolated 368 
from waterbird faeces (Wu et al 2018). Colistin resistance genes have been demonstrated in waste-369 
impacted river water (Wu et al 2018), and especially at STPs (Hembach et al 2017). Although 370 
chromosomally-encoded colistin resistance has been described for many years, its prevalence was 371 
historically generally low. The recent discovery of the mcr-1 gene, that confers colistin resistance 372 
and is plasmid encoded, enabling rapid horizontal transmission of resistance, (Liu and Wong 2013) is 373 
of great clinical concern as colistin is now a ‘last line’ antibiotic used for treating MDR infections in 374 
humans (Velkov et al 2013). The high prevalence of colistin resistance found in our study (35-40%), 375 
along with most colistin resistant isolates being MDR (87% resistant to three or more antibiotics and 376 
26% to five or more antibiotics) is suggestive of horizontal transmission although screening for the 377 
mcr-1 gene by PCR was negative. However, other plasmid-encoded genes for colistin resistance  378 
have been subsequently described  (Xavier et al 2016), and further characterisation of the underlying 379 
mechanism of the colistin resistance found in in our study is underway. Seven out of the nine 380 
ciprofloxacin resistant isolates contained four nonsynonymous mutations in the gyrase A gene 381 
(Figure 4), which had been reported previously, and two had mutations that have not previously 382 
been reported in E. coli. Wildlife can. Therefore, harbour and disperse novel and/ or clinically 383 
important ARGs in the environment. 384 
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In terms of other clinical important resistances, cefpodoxime resistance is a common 385 
indicator of ESBL production (Oliver et al., 2002), also of major concern in human medicine. From 386 
the 53 cefpodoxime resistant E. coli isolated from wildlife, six were ESBL producers, 22 were AmpC 387 
and six were positive for both ESBL and AmpC production (Table 3). ESBLs have previously been 388 
detected in E. coli isolates from a range of wildlife taxa, for example,  32% of E. coli isolates obtained 389 
from  gulls’ faeces (Simões et al 2010), and such findings have been ascribed to contact with human 390 
waste. In our study, significantly more ESBL and/or AmpC – producing E. coli were found in wildlife 391 
samples collected from the STP Site, which suggests that human waste may be a factor driving 392 
ESBL/AmpC resistance in the environment.  393 
  394 
4.3. Conclusions 395 
Taken together, the results of this study support those of previous studies in that they 396 
confirm that wildlife commonly harbour ARB. Whether or not wildlife might be a source for onward 397 
transmission to domestic animals or to humans has not been directly examined. Our study was more 398 
concerned with beginning to investigate the drivers of AMR in wildlife, and in particular the role that 399 
anthropogenic waste, whether of directly human or domestic animal origin, might play in developing 400 
and maintaining that resistance.  Diverse patterns of resistance were found in E. coli from wildlife in 401 
this study, suggesting variation within and between host taxa, between individuals, and over time.  402 
Overall, study site was not associated clearly with AMR, MDR or resistance patterns. However, 403 
resistance to antibiotics used only in human medicine was more prevalent at the STP site than the 404 
Farm and Central sites. Thus, the drivers of AMR in wildlife appear to be more complex than simple 405 
anthropogenic causes. Consequently, care needs to be taken if wildlife are to be used as sentinels of 406 
environmental AMR or pollution.  407 
 408 
  409 
19 
 
Acknowledgements 410 
We would like to thank K. Hemsley and the South Notts Ringing group for help with capturing birds.   411 
 412 
Funding 413 
The project was funded by the University of Nottingham, the University of York and the EPSRC Bridging 414 
the Gaps between the Engineering and Physical Sciences and Antimicrobial Resistance funds to the 415 
University of York and University of Nottingham. 416 
 417 
References 418 
Ahammad ZS, Sreekrishnan TR, Hands CL, Knapp CW, Graham DW (2014). Increased Waterborne 419 
bla(NDM-1) Resistance Gene Abundances Associated with Seasonal Human Pilgrimages to the Upper 420 
Ganges River. Environmental Science & Technology 48: 3014-3020. 421 
 422 
Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J (2010). Call of the wild: 423 
antibiotic resistance genes in natural environments. Nature Reviews Microbiology 8: 251-259. 424 
 425 
Allen SE, Boerlin P, Janecko N, Lumsden JS, Barker IK, Pearl DL et al (2011). Antimicrobial Resistance 426 
in Generic Escherichia coli Isolates from Wild Small Mammals Living in Swine Farm, Residential, 427 
Landfill, and Natural Environments in Southern Ontario, Canada. Applied and Environmental 428 
Microbiology 77: 882-888. 429 
 430 
Arnold KE, Williams NJ, Bennett M (2016). 'Disperse abroad in the land': the role of wildlife in the 431 
dissemination of antimicrobial resistance. Biology Letters 12. 432 
 433 
Bondo KJ, Pearl DL, Janecko N, Boerlin P, Reid-Smith RJ, Parmley J et al (2016). Epidemiology of 434 
Antimicrobial Resistance in Escherichia coli Isolates from Raccoons (Procyon lotor) and the 435 
Environment on Swine Farms and Conservation Areas in Southern Ontario. Plos One 11. 436 
 437 
Bonnedahl J, Drobni M, Gauthier-Clerc M, Hernandez J, Granholm S, Kayser Y et al (2009). 438 
Dissemination of Escherichia coli with CTX-M Type ESBL between Humans and Yellow-Legged Gulls in 439 
the South of France. Plos One 4. 440 
 441 
Briñas L, Zarazaga M, Sáenz Y, Ruiz-Larrea F, Torres C (2002). β-Lactamases in Ampicillin-Resistant 442 
Escherichia coli Isolates from Foods, Humans, and Healthy Animals. Antimicrobial Agents and 443 
Chemotherapy 46: 3156-3163. 444 
20 
 
 445 
Carroll D, Wang J, Fanning S, McMahon BJ (2015). Antimicrobial Resistance in Wildlife: Implications 446 
for Public Health. Zoonoses and Public Health 62: 534-542. 447 
 448 
Carter DL, Docherty KM, Gill SA, Baker K, Teachout J, Vonhof MJ (2018). Antibiotic resistant bacteria 449 
are widespread in songbirds across rural and urban environments. Science of the Total Environment 450 
627: 1234-1241. 451 
 452 
Clarke BO, Smith SR (2011). Review of 'emerging' organic contaminants in biosolids and assessment 453 
of international research priorities for the agricultural use of biosolids. Environ Internat 37: 226-247. 454 
 455 
Cristobal-Azkarate J, Dunn JC, Day JMW, Amabile-Cuevas CF (2014). Resistance to Antibiotics of Clinical 456 
Relevance in the Fecal Microbiota of Mexican Wildlife. Plos One 9. 457 
 458 
D'Costa VM, King CE, Kalan L, Morar M, Sung WWL, Schwarz C et al (2011). Antibiotic resistance is 459 
ancient. Nature 477: 457-461. 460 
 461 
Davies J, Davies D (2010). Origins and Evolution of Antibiotic Resistance. Microbiology and Molecular 462 
Biology Reviews 74: 417-+. 463 
 464 
EUCAST (2016). "The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables 465 
for interpretation of MICs and zone diameters. Version 6.0, 2016. http://www.eucast.org.". 466 
 467 
Excoffier L, Smouse PE, Quattro JM (1992). Analysis of molecular variance inferred from metric 468 
distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 469 
131: 479-491. 470 
 471 
Fahrenfeld N, Ma Y, O'Brien M, Pruden A (2013). Reclaimed water as a reservoir of antibiotic resistance 472 
genes: distribution system and irrigation implications. Frontiers in Microbiology 4: 130-130. 473 
 474 
Furness LE, Campbell A, Zhang L, Gaze WH, McDonald RA (2017). Wild small mammals as sentinels for 475 
the environmental transmission of antimicrobial resistance. Environmental Research 154: 28-34. 476 
 477 
Gilliver M, Bennett M, Begon M, Hazel S, Hart C (1999). Enterobacteria: Antibiotic resistance found in 478 
wild rodents. Nature 401: 233 - 234. 479 
 480 
Guenther S, Grobbel M, Heidemanns K, Schlegel M, Ulrich RG, Ewers C et al (2010). First insights into 481 
antimicrobial resistance among faecal Escherichia coli isolates from small wild mammals in rural areas. 482 
Science of the Total Environment 408: 3519-3522. 483 
 484 
Guenther S, Semmler T, Stubbe A, Stubbe M, Wieler LH, Schaufler K (2017). Chromosomally encoded 485 
ESBL genes in Escherichia coli of ST38 from Mongolian wild birds. Journal of Antimicrobial 486 
Chemotherapy 72: 1310-1313. 487 
 488 
21 
 
Hembach N, Schmid F, Alexander J, Hiller C, Rogall ET, Schwartz T (2017). Occurrence of the mcr-1 489 
Colistin Resistance Gene and other Clinically Relevant Antibiotic Resistance Genes in Microbial 490 
Populations at Different Municipal Wastewater Treatment Plants in Germany. Frontiers in 491 
Microbiology 8. 492 
 493 
Huijbers PMC, Blaak H, de Jong MCM, Graat EAM, Vandenbroucke-Grauls CMJE, Husman AMdR 494 
(2015). Role of the Environment in the Transmission of Antimicrobial Resistance to Humans: A Review. 495 
Environmental Science & Technology 49: 11993-12004. 496 
 497 
Ibrahim DR, Dodd CER, Stekel DJ, Ramsden SJ, Hobman JL (2016). Multidrug resistant, extended 498 
spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from a dairy farm. FEMS Microbiology 499 
Ecology 92: fiw013-fiw013. 500 
 501 
Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M et al (2012). Zoonoses 1 502 
Ecology of zoonoses: natural and unnatural histories. Lancet 380: 1936-1945. 503 
 504 
Literak I, Dolejska M, Radimersky T, Klimes J, Friedman M, Aarestrup FM et al (2010). Antimicrobial-505 
resistant faecal Escherichia coli in wild mammals in central Europe: multiresistant Escherichia coli 506 
producing extended-spectrum beta-lactamases in wild boars. Journal of applied microbiology 108: 507 
1702-1711. 508 
 509 
Liu JL, Wong MH (2013). Pharmaceuticals and personal care products (PPCPs): A review on 510 
environmental contamination in China. Environ Internat 59: 208-224. 511 
 512 
Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J et al (2016). Emergence of plasmid-mediated 513 
colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and 514 
molecular biological study. The Lancet Infectious Diseases 16: 161-168. 515 
 516 
Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS (2016). Antimicrobial resistance. Journal of 517 
the American Medical Association 316: 1193-1204. 518 
 519 
Martinez JL (2009). The role of natural environments in the evolution of resistance traits in pathogenic 520 
bacteria. Proceedings of the Royal Society B-Biological Sciences 276: 2521-2530. 521 
 522 
O'Neill J (2016). Tackling Drug Resistant Infections Globally: Final Report and Recommendations. 523 
 524 
Peakall ROD, Smouse PE (2006). genalex 6: genetic analysis in Excel. Population genetic software for 525 
teaching and research. Molecular Ecology Notes 6: 288-295. 526 
 527 
Radhouani H, Igrejas G, Carvalho C, Pinto L, Gonçalves A, Lopez M et al (2011). Clonal Lineages, 528 
Antibiotic Resistance and Virulence Factors in Vancomycin-Resistant Enterococci Isolated from Fecal 529 
Samples of Red Foxes (Vulpes Vulpes). Journal of Wildlife Diseases 47: 769-773. 530 
 531 
22 
 
Rawat D, Nair D (2010). Extended-spectrum β-lactamases in Gram Negative Bacteria. Journal of Global 532 
Infectious Diseases 2: 263-274. 533 
 534 
Schaufler K, Semmler T, Pickard DJ, de Toro M, de la Cruz F, Wieler LH et al (2016). Carriage of 535 
Extended-Spectrum Beta-Lactamase-Plasmids Does Not Reduce Fitness but Enhances Virulence in 536 
Some Strains of Pandemic E-coli Lineages. Frontiers in Microbiology 7. 537 
 538 
Simões RR, Poirel L, Da Costa PM, Nordmann P (2010). Seagulls and Beaches as Reservoirs for 539 
Multidrug-Resistant Escherichia coli. Emerging Infectious Diseases 16: 110-112. 540 
 541 
Srinivasan R, Karaoz U, Volegova M, MacKichan J, Kato-Maeda M, Miller S et al (2015). Use of 16S 542 
rRNA Gene for Identification of a Broad Range of Clinically Relevant Bacterial Pathogens. PLOS ONE 543 
10: e0117617. 544 
 545 
Stedt J, Bonnedahl J, Hernandez J, McMahon BJ, Hasan B, Olsen B et al (2014). Antibiotic resistance 546 
patterns in Escherichia coli from gulls in nine European countries. Infection Ecology & Epidemiology 4: 547 
10.3402/iee.v3404.21565. 548 
 549 
Sun L, Klein EY, Laxminarayan R (2012). Seasonality and Temporal Correlation between Community 550 
Antibiotic Use and Resistance in the United States. Clin Infect Dis 55: 687-694. 551 
 552 
Taylor NGH, Verner-Jeffreys DW, Baker-Austin C (2011). Aquatic systems: maintaining, mixing and 553 
mobilising antimicrobial resistance? Trends in Ecology & Evolution 26: 278-284. 554 
 555 
VanderWaal KL, Atwill ER, Isbell LA, McCowan B (2014). Linking social and pathogen transmission 556 
networks using microbial genetics in giraffe (Giraffa camelopardalis). J Anim Ecol 83: 406-414. 557 
 558 
Velkov T, Roberts KD, Nation RL, Thompson PE, Li J (2013). Pharmacology of polymyxins: new insights 559 
into an ‘old’ class of antibiotics. Future Microbiology 8: 10.2217/fmb.2213.2239. 560 
 561 
Versalovic J, Koeuth T, Lupski R (1991). Distribution of repetitive DNA sequences in eubacteria and 562 
application to fingerprinting of bacterial genomes. Nucleic Acids Research 19: 6823-6831. 563 
 564 
Vittecoq M, Godreuil S, Prugnolle F, Durand P, Brazier L, Renaud N et al (2016). REVIEW: Antimicrobial 565 
resistance in wildlife. J App Ecol 53: 519-529. 566 
 567 
von Wintersdorff CJH, Penders J, van Niekerk JM, Mills ND, Majumder S, van Alphen LB et al (2016). 568 
Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer. 569 
Frontiers in Microbiology 7. 570 
 571 
Waite DW, Taylor MW (2014). Characterizing the avian gut microbiota: membership, driving 572 
influences, and potential function. Frontiers in Microbiology 5. 573 
 574 
23 
 
Williams NJ, Sherlock C, Jones TR, Clough HE, Telfer SE, Begon M et al (2011). The prevalence of 575 
antimicrobial-resistant Escherichia coli in sympatric wild rodents varies by season and host. Journal of 576 
applied microbiology 110: 962-970. 577 
 578 
Wu J, Huang Y, Rao D, Zhang Y, Yang K (2018). Evidence for environmental dissemination of antibiotic 579 
resistance mediated by wild birds. Frontiers in Microbiology 9. 580 
 581 
Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H et al (2016). Identification of a 582 
novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. 583 
Eurosurveillance 21: 30280. 584 
 585 
D'Costa VM, King CE, Kalan L, Morar M, Sung WWL, Schwarz C et al (2011). Antibiotic resistance is 586 
ancient. Nature 477: 457-461. 587 
 588 
Davies J, Davies D (2010). Origins and Evolution of Antibiotic Resistance. Microbiology and Molecular 589 
Biology Reviews 74: 417. 590 
 591 
EUCAST (2016). "The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables 592 
for interpretation of MICs and zone diameters. Version 6.0, 2016. http://www.eucast.org.". 593 
 594 
Excoffier L, Smouse PE, Quattro JM (1992). Analysis of molecular variance inferred from metric 595 
distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 596 
131: 479-491. 597 
 598 
Fahrenfeld N, Ma Y, O'Brien M, Pruden A (2013). Reclaimed water as a reservoir of antibiotic resistance 599 
genes: distribution system and irrigation implications. Frontiers in Microbiology 4: 130-130. 600 
 601 
Furness LE, Campbell A, Zhang L, Gaze WH, McDonald RA (2017). Wild small mammals as sentinels for 602 
the environmental transmission of antimicrobial resistance. Environmental Research 154: 28-34. 603 
 604 
Gilliver M, Bennett M, Begon M, Hazel S, Hart C (1999). Enterobacteria: Antibiotic resistance found in 605 
wild rodents. Nature 401: 233 - 234. 606 
 607 
Guenther S, Grobbel M, Heidemanns K, Schlegel M, Ulrich RG, Ewers C et al (2010). First insights into 608 
antimicrobial resistance among faecal Escherichia coli isolates from small wild mammals in rural areas. 609 
Science of the Total Environment 408: 3519-3522. 610 
 611 
Guenther S, Semmler T, Stubbe A, Stubbe M, Wieler LH, Schaufler K (2017). Chromosomally encoded 612 
ESBL genes in Escherichia coli of ST38 from Mongolian wild birds. Journal of Antimicrobial 613 
Chemotherapy 72: 1310-1313. 614 
 615 
Hembach N, Schmid F, Alexander J, Hiller C, Rogall ET, Schwartz T (2017). Occurrence of the mcr-1 616 
Colistin Resistance Gene and other Clinically Relevant Antibiotic Resistance Genes in Microbial 617 
24 
 
Populations at Different Municipal Wastewater Treatment Plants in Germany. Frontiers in 618 
Microbiology 8. 619 
 620 
Huijbers PMC, Blaak H, de Jong MCM, Graat EAM, Vandenbroucke-Grauls CMJE, Husman AMdR 621 
(2015). Role of the Environment in the Transmission of Antimicrobial Resistance to Humans: A Review. 622 
Environmental Science & Technology 49: 11993-12004. 623 
 624 
Ibrahim DR, Dodd CER, Stekel DJ, Ramsden SJ, Hobman JL (2016). Multidrug resistant, extended 625 
spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from a dairy farm. FEMS Microbiology 626 
Ecology 92: fiw013-fiw013. 627 
 628 
Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M et al (2012). Zoonoses 1 629 
Ecology of zoonoses: natural and unnatural histories. Lancet 380: 1936-1945. 630 
 631 
Literak I, Dolejska M, Radimersky T, Klimes J, Friedman M, Aarestrup FM et al (2010). Antimicrobial-632 
resistant faecal Escherichia coli in wild mammals in central Europe: multiresistant Escherichia coli 633 
producing extended-spectrum beta-lactamases in wild boars. Journal of Applied Microbiology 108: 634 
1702-1711. 635 
 636 
Liu JL, Wong MH (2013). Pharmaceuticals and personal care products (PPCPs): A review on 637 
environmental contamination in China. Environment International 59: 208-224. 638 
 639 
Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J et al (2016). Emergence of plasmid-mediated 640 
colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and 641 
molecular biological study. The Lancet Infectious Diseases 16: 161-168. 642 
 643 
Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS (2016). Antimicrobial resistance. Journal of 644 
the American Medical Association 316: 1193-1204. 645 
 646 
Martinez JL (2009). The role of natural environments in the evolution of resistance traits in pathogenic 647 
bacteria. Proceedings of the Royal Society B-Biological Sciences 276: 2521-2530. 648 
 649 
O'Neill J (2016). Tackling Drug Resistant Infections Globally: Final Report and Recommendations. 650 
 651 
Peakall ROD, Smouse PE (2006). genalex 6: genetic analysis in Excel. Population genetic software for 652 
teaching and research. Molecular Ecology Notes 6: 288-295. 653 
 654 
Radhouani H, Igrejas G, Carvalho C, Pinto L, Gonçalves A, Lopez M et al (2011). Clonal Lineages, 655 
Antibiotic Resistance and Virulence Factors in Vancomycin-Resistant Enterococci Isolated from Fecal 656 
Samples of Red Foxes (Vulpes vulpes). Journal of Wildlife Diseases 47: 769-773. 657 
 658 
Rawat D, Nair D (2010). Extended-spectrum β-lactamases in Gram Negative Bacteria. Journal of Global 659 
Infectious Diseases 2: 263-274. 660 
 661 
25 
 
Schaufler K, Semmler T, Pickard DJ, de Toro M, de la Cruz F, Wieler LH et al (2016). Carriage of 662 
Extended-Spectrum Beta-Lactamase-Plasmids Does Not Reduce Fitness but Enhances Virulence in 663 
Some Strains of Pandemic E-coli Lineages. Frontiers in Microbiology 7. 664 
 665 
Simões RR, Poirel L, Da Costa PM, Nordmann P (2010). Seagulls and Beaches as Reservoirs for 666 
Multidrug-Resistant Escherichia coli. Emerging Infectious Diseases 16: 110-112. 667 
 668 
Srinivasan R, Karaoz U, Volegova M, MacKichan J, Kato-Maeda M, Miller S et al (2015). Use of 16S 669 
rRNA Gene for Identification of a Broad Range of Clinically Relevant Bacterial Pathogens. PLOS ONE 670 
10: e0117617. 671 
 672 
Stedt J, Bonnedahl J, Hernandez J, McMahon BJ, Hasan B, Olsen B et al (2014). Antibiotic resistance 673 
patterns in Escherichia coli from gulls in nine European countries. Infection Ecology & Epidemiology 4: 674 
10.3402/iee.v3404.21565. 675 
 676 
Sun L, Klein EY, Laxminarayan R (2012). Seasonality and Temporal Correlation between Community 677 
Antibiotic Use and Resistance in the United States. Clinical Infectious Diseases 55: 687-694. 678 
 679 
Taylor NGH, Verner-Jeffreys DW, Baker-Austin C (2011). Aquatic systems: maintaining, mixing and 680 
mobilising antimicrobial resistance? Trends in Ecology & Evolution 26: 278-284. 681 
 682 
VanderWaal KL, Atwill ER, Isbell LA, McCowan B (2014). Linking social and pathogen transmission 683 
networks using microbial genetics in giraffe (Giraffa camelopardalis). J Anim Ecol 83: 406-414. 684 
 685 
Velkov T, Roberts KD, Nation RL, Thompson PE, Li J (2013). Pharmacology of polymyxins: new insights 686 
into an ‘old’ class of antibiotics. Future Microbiology 8: 10.2217/fmb.2213.2239. 687 
 688 
Versalovic J, Koeuth T, Lupski R (1991). Distribution of repetitive DNA sequences in eubacteria and 689 
application to fingerprinting of bacterial genomes. Nucleic Acids Research 19: 6823-6831. 690 
 691 
Vittecoq M, Godreuil S, Prugnolle F, Durand P, Brazier L, Renaud N et al (2016). REVIEW: Antimicrobial 692 
resistance in wildlife. Journal of  Applied Ecology 53: 519-529. 693 
 694 
von Wintersdorff CJH, Penders J, van Niekerk JM, Mills ND, Majumder S, van Alphen LB et al (2016). 695 
Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer. 696 
Frontiers in Microbiology 7. 697 
 698 
Williams NJ, Sherlock C, Jones TR, Clough HE, Telfer SE, Begon M et al (2011). The prevalence of 699 
antimicrobial-resistant Escherichia coli in sympatric wild rodents varies by season and host. Journal of 700 
Applied Microbiology 110: 962-970. 701 
 702 
Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H et al (2016). Identification of a 703 
novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. 704 
Eurosurveillance 21: 30280. 705 
26 
 
Figure Legends 706 
Figure 1: Inter-site variation in the percentage prevalence of faecal samples testing positive (solid 707 
blue bars) or negative (orange hatched bars) for a) E. coli. Boxes on the bars show the number of 708 
samples in each category.  709 
 710 
Figure 2. ERIC profile of E. coli isolated from both small mammals and birds at Farm site (light green, 711 
mammals; dark green birds) Central site (red, mammals; dark red, birds) and STP site (light purple, 712 
mammals; dark purple, birds). Horizontal lines demonstrate significant clusters (I - V) based on 50 % 713 
cut-off (vertical line). Red cells demonstrate resistance to each antibiotic: Amp – ampicillin; Cef – 714 
cefpodoxime; Col – colistin; Apra – apramycin; Imi – imipenem; Trim – trimethoprim; Tet – 715 
tetracycline; Cip – ciprofloxacin 716 
 717 
Figure 3: Site-specific patterns of resistance in E. coli isolates: a) AMR: The percentage of faecal 718 
samples which contained E. coli susceptible to ≥1 antimicrobial (negative = orange hatched bars) or 719 
resistant to one or more antimicrobial drugs (positive = solid blue bars); b) MDR - The percentage of 720 
samples containing E. coli that were resistant to ≥3 antibiotics (positive = resistant = solid blue 721 
bars); c) Prevalence of resistance to 1 – 7 different antibiotics. The sites were Farm, Central and STP. 722 
 723 
Figure 4. Mutations of ciprofloxin-resistant E. coli isolated from small mammals (blue boxes). 724 
Translated sequences of gyraseA gene from ciprofloxacin resistant E. coli isolates compared to the 725 
known sensitive reference strain K-12. 726 
  727 
27 
 
Table 1: Final binomial logistic regression model outputs explaining prevalence of a) E. coli; b) 728 
AMR ≥1 antibiotic; c) MDR (AMR ≥3 antibiotics). The coefficients for the Site variable are compared to 729 
the Central Site, for the Taxa variable was compared to birds and for the Season variable was 730 
compared to Autumn. 731 
 Nagelkerke 
R2  
χ2 (df) Wald (df) p-value Odds ratio 95% C.I. 
a) E. coli  21% 67.50 (4)  < 0.0001   
Site:  
Farm 
STP 
  16.21 (2) 
15.07 (1) 
0.23 (1) 
< 0.0001 
< 0.0001 
0.63 
 
3.51 
1.14 
 
1.86 – 6.60 
0.67 – 1.93 
Taxa   45.75 (1) < 0.0001 9.26 4.86 - 17.66 
Season   3.89 (1) 0.048 1.57  1.00 - 2.46 
b) AMR  14.4% 29.97 (4)  < 0.0001   
Site: 
Farm 
STP 
  4.75 (2) 
1.17 (1) 
4.742 (1) 
0.093 
0.28 
0.029 
 
1.44 
2.11 
 
0.74 - 2.79 
1.08 - 4.73 
Taxa   3.64 (1) 0.056 2.48 0.98 - 6.32 
Season   23.93 (1) < 0.0001 3.96 2.28 - 6.89 
c) MDR 25.9% 40.91 (4)  < 0.0001   
Site: 
Farm 
STP 
  8.02 (2) 
0.05 (1) 
7.07 (1) 
0.018 
0.82 
0.008 
 
1.09 
3.37 
 
0.51 - 2.34 
1.38 - 8.26 
Taxa   14.30 (1) < 0.0001 12.53 3.38 – 46.43 
Season   0.57 (1) 0.45 1.34 0.63 - 2.84 
 732 
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Table 2: Frequencies of MDR profiles for combinations of antibiotics to which E. coli isolates were 733 
resistant for faecal samples collected from birds and mammals captured at the STP, Central and Farm 734 
sites. Only profiles that were found at two or more individuals are presented. Amp – ampicillin; Cef – 735 
cefpodoxime; Col – colistin; Apra – apramycin; Imi – imipenem; Trim – trimethoprim; Tet – 736 
tetracycline; Cip – ciprofloxacin 737 
 738 
 Antibiotics  Farm Central STP Totals 
Amp  Tet  Col 7 8 8 23 
Apra  Col  Tet 2 3 2 7 
Amp Cip Tet 5 0 0 5 
Amp  Tet  Cef 0 1 3 4 
Amp  Tet  Trim 0 2 2 4 
Amp  Apra  Tet 1 2 1 4 
Col  Cef Tet 0 1 2 3 
Apra  Trim  Col 0 0 2 2 
Amp Apra Cef 1 1 0 2 
Amp  Apra  Col  Tet 2 5 2 9 
Amp Tet Trim Col 2 1 3 6 
Col  Trim Cef  Tet 0 1 2 3 
Amp Tet  Cef Col 0 0 3 3 
Amp  Cef  Trim  Col 1 0 2 3 
Apra  Tetra  Cef Col 1 1 0 2 
Amp  Apra  Trim  Col 0 2 0 2 
Amp  Apra  Cef  Trim  Col 3 2 3 8 
Amp  Col  Trim  Cef  Tet 1 2 4 7 
Amp  Apra  Tet  Trim  Col 2 0 0 2 
Amp  Apra  Tet  Cef  Trim  Col 1 2 1 4 
 739 
 740 
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Table 3: Number of AmpC and ESBL producing E. coli isolates for bird and mammal samples collected 741 
at the Farm (livestock waste dominated), Central (no waste source) and STP (human waste dominated) 742 
sites. The percentages in brackets were calculated across all 53 cefpodoxime resistant isolates that 743 
were tested for AmpC and ESBL activity. 744 
 745 
Site Mammal Bird 
 AmpC ESBL AmpC & 
ESBL 
Negative AmpC ESBL AmpC & 
ESBL 
Negative 
Farm  4 (8%) 0 2 (4%) 5 (9%) 0 0 0 2 (4%) 
Central 6 (11%) 2 (4%) 1 (2%) 4 (8%) 1 (2%) 0 0 0 
STP 7 (13%) 4 (8%) 3 (6%)   7 (13%) 4 (8%) 0 0 1 (2%) 
Total 17 (32%) 6 (12%) 6 (12%) 16 (30%) 5 (9%) 0 0 3 (6%) 
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